Amperometric Bioplatforms To Detect Regional DNA Methylation with Single-Base Sensitivity.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
07 04 2020
Historique:
pubmed: 20 2 2020
medline: 21 1 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

This work reports the first bioplatform able to determine electrochemically 5-hydroxymethylcytosine (5-hmC) methylation events at localized sites and single-base sensitivity. The described bioplatform relies on a specific antibody (anti-5-hmC), further conjugated with commercial bioreagents loaded with multiple horseradish peroxidase (HRP) molecules, recognizing the epimark in a target DNA, captured through hybridization onto streptavidin-magnetic microbeads (Strep-MBs) modified with a complementary DNA capture probe. The electrochemical detection is performed by amperometry (-0.20 V vs Ag pseudoreference electrode) at disposable screen-printed carbon electrodes (SPCEs) in the presence of H

Identifiants

pubmed: 32073832
doi: 10.1021/acs.analchem.0c00628
doi:

Substances chimiques

5-hydroxymethylcytosine 1123-95-1
5-Methylcytosine 6R795CQT4H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5604-5612

Auteurs

Eloy Povedano (E)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Víctor Ruiz-Valdepeñas Montiel (V)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Maria Gamella (M)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

María Pedrero (M)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Rodrigo Barderas (R)

Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.

Alberto Peláez-García (A)

Molecular Pathology and Therapeutic Targets Group, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain.

Marta Mendiola (M)

Molecular Pathology and Therapeutic Targets Group, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain.
Translational Oncology Group, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain.

David Hardisson (D)

Molecular Pathology and Therapeutic Targets Group, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain.

Jaime Feliú (J)

Center for Biomedical Research in the Cancer Network, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Paloma Yáñez-Sedeño (P)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Susana Campuzano (S)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

José M Pingarrón (JM)

Departamento de Quı́mica Analı́tica, Facultad de CC. Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH